 EXFORGE D
|
Siegfried
|
| valsartán+hidrocloroti.+amlodip. |
Antihipertensivo |
| 160/12.5/10 mg comp.x 28 | $53.793,03 | (19/06/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $26.499,03 |
|
|
|
|
| 160/12.5/5 mg comp.x 28 | $54.309,74 | (19/06/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $26.753,56 |
|
|
|
|
| 160/25/10 mg comp.x 28 | $54.309,74 | (19/06/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $26.753,56 |
|
|
|
|
| 160/25/5 mg comp.x 28 | $54.309,74 | (19/06/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $26.753,56 |
|
|
|
|
| 320/25/10 mg comp.x 28 | $57.435,59 | (19/06/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $28.293,40 |
|
|
|
|
| |
